Baird Medical to Showcase Microwave Ablation Innovations at Upcoming Microcap Conference

Baird Medical to Attend Microcap Conference at Borgata Hotel

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a prominent player in microwave ablation technology, is set to participate in the much-anticipated Microcap Conference from January 28 to January 30, 2025. This event will take place at the Borgata Hotel in Atlantic City, New Jersey, and aims to connect microcap company executives with institutional investors and industry thought leaders.

As a specialist in the design and development of advanced needles and apparatus for microwave ablation of thyroid nodules, Baird Medical offers a minimally invasive alternative to traditional open neck surgery. The company’s innovative solutions provide substantial benefits to patients on a global scale, particularly following its FDA 510(k) clearance obtained in November 2023. This milestone allows the company to expand its operations and introduce its products in the United States while solidifying its strong market presence in China.

Haimei Wu, Chairwoman of Baird Medical, expressed enthusiasm about the opportunity to engage with investors and industry peers during the conference. "Our recent FDA clearance marks a significant step forward, enabling us to extend our pioneering solutions to patients in the U.S. market. We are keen to showcase our developments and discuss our future vision for minimally invasive treatment technologies at this vital industry event," she stated.

The Microcap Conference is known for its dynamic environment, offering an incredible platform for networking, insights, and presentations related to emerging investment opportunities. Throughout the conference, Baird Medical's leadership team is scheduled to deliver presentations and hold one-on-one meetings with potential investors.

Interested attendees are encouraged to visit Baird Medical's booth or set up meetings in advance by reaching out via email at [email protected]. This conference marks a significant opportunity for the company to highlight its recent achievements and plans for future growth.

In terms of healthcare innovations, Baird Medical focuses on utilizing microwave ablation technology to treat various medical conditions, including thyroid nodules, breast diseases, uterine fibroids, and liver cancer. By employing minimally invasive techniques, the company aims to enhance patient care through precision and efficiency in its medical devices.

Baird Medical remains dedicated to advancing healthcare solutions and improving patient outcomes worldwide, underpinning its future strategies with strong market research and development.

For further details about Baird Medical and its innovations in microwave ablation technology, please visit bairdmed.com.

Forward-Looking Statements: This article contains forward-looking statements per the United States Private Securities Litigation Reform Act of 1995. While these statements reflect Baird Medical's current expectations, they are subject to risks and uncertainties that could lead to actual outcomes differing materially from those discussed. Factors that could influence these outcomes include economic conditions, regulatory changes, and market dynamics. Readers are cautioned against placing undue reliance on forward-looking statements, and Baird Medical will not update these statements unless legally mandated.